Skip to main content
TTrialFinder
TrialFinder is for informational purposes only and does not provide medical advice. Always talk to your doctor.
RECRUITINGOBSERVATIONAL

Lebanese Interhospital Pneumococcal Surveillance Program

Lebanese Interhospital Pneumococcal Surveillance Program (LIPSP)

Important: This information is not medical advice. Talk to your doctor about whether a clinical trial is right for you.

About This Trial

Streptococcus pneumoniae (pneumococcus) is a bacterium that causes severe infections in children and adults such as meningitis, pneumonia, and blood stream infection. There are many types of these bacteria defined by the type of sugar coat that they have. These are classified as serotypes. There are common serotypes that cause severe disease and are preventable by vaccination of children. Other less common types are more difficult to prevent. The investigators aim to determine the serotypes that cause invasive pneumococcal disease in Lebanon and to study their sensitivity to different antibiotics. The investigators will collect bacterial isolates from different hospitals in Lebanon isolated from the blood or spinal fluid of patients with invasive pneumococcal disease. This information will help the investigators determine the usefulness of available pneumococcal vaccines in preventing these infections. The data will be distributed to all primary care physicians treating children in Lebanon and will be shared with the Ministry of Health.

Who May Be Eligible (Plain English)

Who May Qualify: - Samples included in the study are those that are: - culture proven - invasive pneumococcal infections - in patients of all ages admitted to different hospitals all over Lebanon - Acceptable samples include: - positive isolates from blood - cerebrospinal fluid - other normally sterile body sites such as empyema fluid, abscesses, joint fluid, middle ear fluid obtained by tympanocentesis in the operating room, and lung needle aspiration Who Should NOT Join This Trial: - non S. pneumoniae isolates Always talk to your doctor about whether this trial is right for you.

Original Eligibility Criteria

View original clinical language
Inclusion Criteria: * Samples included in the study are those that are: * culture proven * invasive pneumococcal infections * in patients of all ages admitted to different hospitals all over Lebanon * Acceptable samples include: * positive isolates from blood * cerebrospinal fluid * other normally sterile body sites such as empyema fluid, abscesses, joint fluid, middle ear fluid obtained by tympanocentesis in the operating room, and lung needle aspiration Exclusion Criteria: * non S. pneumoniae isolates

Locations (1)

American University of Beirut
Beirut, Lebanon